Best Medical Specialties Stocks 2021
$ 4.29 K to $ 234.95 B
$0.00 to $1,439.08
-94.56% to 178.35%
-2028.3 to 3149.39
Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, the company is here to support them. Its global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.
Thermo Fisher Scientific Inc. or TMO is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 234.95 B. Marc Casper is the CEO of the company. Total employees of Thermo Fisher Scientific Inc. are 13,000. The P/E Ratio of Thermo Fisher Scientific Inc. is 38.13 and year till date stock price change percent is 15.95%.
Abbott Laboratories

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Its portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.
Abbott Laboratories or ABT is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 197.08 B. Robert Ford is the CEO of the company. Total employees of Abbott Laboratories are 109,000. The P/E Ratio of Abbott Laboratories is 35.62 and year till date stock price change percent is 4.45%.
Danaher Corp.

Danaher Corporation is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 69,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.
Danaher Corp. or DHR is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 194.50 B. Rainer Blair is the CEO of the company. Total employees of Danaher Corp. are 2,020. The P/E Ratio of Danaher Corp. is 44.74 and year till date stock price change percent is 16.53%.
Intuitive Surgical Inc

Intuitive, headquartered in Sunnyvale, California, is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Intuitive believes that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, it expands the potential of physicians to heal without constraints.
Intuitive Surgical Inc or ISRG is traded on NASDAQ. The total market value of the company is $ 175.28 B. Gary Guthart is the CEO of the company. Total employees of Intuitive Surgical Inc are 8,081. The P/E Ratio of Intuitive Surgical Inc is 84.75 and year till date stock price change percent is 45.65%.
Stryker Corp.

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stryker Corp. or SYK is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 137.35 B. Kevin Lobo is the CEO of the company. Total employees of Stryker Corp. are 2,020. The P/E Ratio of Stryker Corp. is 40.18 and year till date stock price change percent is 20.78%.
Boston Scientific Corp.

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, The company advances science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Boston Scientific Corp. or BSX is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 120.45 B. Michael Mahoney is the CEO of the company. Total employees of Boston Scientific Corp. are 2,020. The P/E Ratio of Boston Scientific Corp. is 65.96 and year till date stock price change percent is 40.93%.
Medtronic Plc

Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Medtronic Plc or MDT is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 113.60 B. Geoffrey Martha is the CEO of the company. Total employees of Medtronic Plc are 90,000. The P/E Ratio of Medtronic Plc is 29.82 and year till date stock price change percent is 9.34%.
Becton, Dickinson And Co.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
Becton, Dickinson And Co. or BDX is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 70.07 B. Thomas Polen is the CEO of the company. Total employees of Becton, Dickinson And Co. are 72,000. The P/E Ratio of Becton, Dickinson And Co. is 50.08 and year till date stock price change percent is 0.22%.
Edwards Lifesciences Corp

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.
Edwards Lifesciences Corp or EW is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 42.14 B. Michael Mussallem is the CEO of the company. Total employees of Edwards Lifesciences Corp are 14,900. The P/E Ratio of Edwards Lifesciences Corp is 28.79 and year till date stock price change percent is -8.27%.
Idexx Laboratories, Inc.

IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, offering diagnostic and software products and services that deliver solutions and insights to practicing veterinarians around the world. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs more than 9,000 people and offers products to customers in over 175 countries.
Idexx Laboratories, Inc. or IDXX is traded on NASDAQ. The total market value of the company is $ 39.62 B. Jonathan Jay Mazelsky is the CEO of the company. Total employees of Idexx Laboratories, Inc. are 9,300. The P/E Ratio of Idexx Laboratories, Inc. is 47.7 and year till date stock price change percent is -13.43%.
Resmed Inc.

ResMed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, the company improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.
Resmed Inc. or RMD is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 36.00 B. Michael Farrell is the CEO of the company. Total employees of Resmed Inc. are 7,770. The P/E Ratio of Resmed Inc. is 35.41 and year till date stock price change percent is 43.13%.
Mettler-Toledo International, Inc.

METTLER TOLEDO is a leading international manufacturer of precision measuring instruments. The company is the world's largest manufacturer and supplier of weighing systems for laboratories, industry and food retail. METTLER TOLEDO is one of the three leading suppliers of various complementary measuring technologies and a leading supplier of automated pharmaceutical research and ingredient development systems. Moreover, the company is the world's biggest manufacturer and supplier of metal recognition systems for the production and packaging industry.
Mettler-Toledo International, Inc. or MTD is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 30.54 B. Oliver Filliol is the CEO of the company. Total employees of Mettler-Toledo International, Inc. are 14,900. The P/E Ratio of Mettler-Toledo International, Inc. is 39.6 and year till date stock price change percent is 18.54%.
Dexcom Inc

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
Dexcom Inc or DXCM is traded on NASDAQ. The total market value of the company is $ 27.79 B. Kevin Sayer is the CEO of the company. Total employees of Dexcom Inc are 5,500. The P/E Ratio of Dexcom Inc is 43.89 and year till date stock price change percent is -44.3%.
Steris Plc

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Steris Plc or STE is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 23.78 B. Walter Rosebrough is the CEO of the company. Total employees of Steris Plc are 13,000. The P/E Ratio of Steris Plc is 59.83 and year till date stock price change percent is 10.04%.
Zimmer Biomet Holdings Inc

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
Zimmer Biomet Holdings Inc or ZBH is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 23.51 B. Bryan Hanson is the CEO of the company. Total employees of Zimmer Biomet Holdings Inc are 20,000. The P/E Ratio of Zimmer Biomet Holdings Inc is 24.05 and year till date stock price change percent is -4.7%.
West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support its customers by delivering over 40 billion components and devices each year.
West Pharmaceutical Services, Inc. or WST is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 22.75 B. Eric Green is the CEO of the company. Total employees of West Pharmaceutical Services, Inc. are 9,200. The P/E Ratio of West Pharmaceutical Services, Inc. is 44.55 and year till date stock price change percent is -10.81%.
Cooper Companies, Inc.

CooperCompanies ("Cooper") is a global medical device company. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries.
Cooper Companies, Inc. or COO is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 21.05 B. Albert White is the CEO of the company. Total employees of Cooper Companies, Inc. are 12,000. The P/E Ratio of Cooper Companies, Inc. is 62.19 and year till date stock price change percent is 11.75%.
Waters Corp.

Waters Corporation, the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,000 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.
Waters Corp. or WAT is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 20.56 B. Christopher O'Connell is the CEO of the company. Total employees of Waters Corp. are 7,400. The P/E Ratio of Waters Corp. is 34.53 and year till date stock price change percent is 5.18%.
Baxter International Inc.

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
Baxter International Inc. or BAX is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 19.36 B. Jose Almeida is the CEO of the company. Total employees of Baxter International Inc. are 2,020. The P/E Ratio of Baxter International Inc. is 7.77 and year till date stock price change percent is 0.46%.
Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.
Hologic, Inc. or HOLX is traded on NASDAQ. The total market value of the company is $ 18.87 B. Stephen MacMillan is the CEO of the company. Total employees of Hologic, Inc. are 5,814. The P/E Ratio of Hologic, Inc. is 27.92 and year till date stock price change percent is 13.62%.
Align Technology, Inc.

Align Technology designs, manufactures and offers the Invisalign® system, the most advanced clear aligner system in the world, iTero® intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 200 thousand doctor customers, and is key to accessing Align's 500 million consumer market opportunity worldwide. Align has helped doctors treat over 9.6 million patients with the Invisalign system and is driving the evolution in digital dentistry through the Align Digital Platform, its integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners.
Align Technology, Inc. or ALGN is traded on NASDAQ. The total market value of the company is $ 17.72 B. Joseph Hogan is the CEO of the company. Total employees of Align Technology, Inc. are 18,070. The P/E Ratio of Align Technology, Inc. is 40.21 and year till date stock price change percent is -13.3%.
Abiomed Inc.

Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Abiomed Inc. or ABMD is traded on NASDAQ. The total market value of the company is $ 17.18 B. Michael Minogue is the CEO of the company. Total employees of Abiomed Inc. are 1,725. The P/E Ratio of Abiomed Inc. is 65.69 and year till date stock price change percent is 0.06%.
Varian Medical Systems, Inc.

Varian Medical Systems, Inc. or VAR is traded on NEW YORK STOCK EXCHANGE, INC.. The total market value of the company is $ 16.26 B. Dow Wilson is the CEO of the company. Total employees of Varian Medical Systems, Inc. are . The P/E Ratio of Varian Medical Systems, Inc. is 58.44 and year till date stock price change percent is 1.18%.
Perkinelmer, Inc.

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.
Perkinelmer, Inc. or PKI is traded on NEW YORK STOCK EXCHANGE INC.. The total market value of the company is $ 14.46 B. Prahlad Singh is the CEO of the company. Total employees of Perkinelmer, Inc. are 2,019. The P/E Ratio of Perkinelmer, Inc. is 15.14 and year till date stock price change percent is -17.73%.
Insulet Corporation

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
Insulet Corporation or PODD is traded on NASDAQ. The total market value of the company is $ 14.22 B. Shacey Petrovic is the CEO of the company. Total employees of Insulet Corporation are 1,900. The P/E Ratio of Insulet Corporation is 38.7 and year till date stock price change percent is -6.61%.